Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Y-mAbs Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
YMAB
Nasdaq
8731
https://www.ymabs.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Y-mAbs Therapeutics Inc
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
- May 9th, 2024 3:58 pm
Y-mAbs Therapeutics Inc (YMAB) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
- May 9th, 2024 7:04 am
Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
- May 9th, 2024 1:57 am
Y-mAbs Therapeutics Reports Q1 2024 Results: Aligns with EPS Projections, Misses Revenue Estimates
- May 7th, 2024 10:12 pm
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates
- May 7th, 2024 9:55 pm
Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
- May 7th, 2024 8:05 pm
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024
- Apr 26th, 2024 11:05 am
Y-mAbs to Present at 2024 ASCO Annual Meeting
- Apr 25th, 2024 8:05 pm
Y-mAbs Therapeutics (NASDAQ:YMAB) rises 9.6% this week, taking one-year gains to 161%
- Apr 18th, 2024 1:09 pm
Wall Street Analysts Think YmAbs Therapeutics (YMAB) Could Surge 31.33%: Read This Before Placing a Bet
- Mar 28th, 2024 1:55 pm
YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains?
- Mar 20th, 2024 11:37 am
Y-mAbs Therapeutics Announces Resignation of Chief Financial Officer
- Mar 14th, 2024 1:05 pm
Wall Street Analysts See a 31.41% Upside in Y-mAbs Therapeutics, Inc. (YMAB): Can the Stock Really Move This High?
- Mar 12th, 2024 1:55 pm
Are You Looking for a Top Momentum Pick? Why Y-mAbs Therapeutics, Inc. (YMAB) is a Great Choice
- Mar 5th, 2024 5:00 pm
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2023 Earnings Call Transcript
- Mar 4th, 2024 1:45 pm
Y-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
- Mar 4th, 2024 12:30 pm
Y-mAbs Therapeutics Full Year 2023 Earnings: Beats Expectations
- Mar 3rd, 2024 2:40 pm
Q4 2023 Y-mAbs Therapeutics Inc Earnings Call
- Mar 2nd, 2024 2:42 am
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q4 Loss, Tops Revenue Estimates
- Feb 29th, 2024 10:25 pm
Y-mAbs Therapeutics Inc (YMAB) Reports Strong Revenue Growth in Q4 and Full Year 2023
- Feb 29th, 2024 9:37 pm
Scroll